EP3880654
2-Formýl-3-hýdroxýfenýloxýmetýl-efnasambönd sem eru fær um að stilla hemóglóbín
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
18.11.2019EP published:
29.12.2021EP application number:
19818401.2
EP translation filed:
19.1.2022Grant published:
15.2.2022EPO information:
European Patent Register
Max expiry date:
17.11.2039Expiry date:
17.11.2026Next due date:
30.11.2026
Title in English:
2-FORMYL-3-HYDROXYPHENYLOXYMETHYL COMPOUNDS CAPABLE OF MODULATING HEMOGLOBINLanguage of the patent:
English
Timeline
Today
18.11.2019EP application
29.12.2021EP Publication
19.1.2022Translation submitted
15.2.2022Registration published
17.11.2026Expires
Owner
Name:
Global Blood Therapeutics, Inc.Address:
181 Oyster Point Blvd., South San Francisco, CA 94080, US
Inventor
Name:
LI, ZheAddress:
San Francisco, CA 94080, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201862769196 PDate:
19.11.2018Country:
US
Number:
201962821314 PDate:
20.3.2019Country:
US
Number:
201962848773 PDate:
16.5.2019Country:
US
Number:
201962883313 PDate:
6.8.2019Country:
US
Classification
Categories:
C07D 207/08, C07D 211/22, C07D 265/30, C07D 279/12, C07D 401/06, C07D 401/10, C07D 403/06, C07D 413/06, C07D 417/06, A61P 7/06, A61K 31/40, A61K 31/4427, A61K 31/445, A61K 31/4523, A61K 31/497, A61K 31/5375, A61K 31/5377, A61K 31/54, A61K 31/541
Annual fees
Number
Paid
Expires
Payer
Number: 4
Paid: 6.10.2022
Expires: 17.11.2023
Payer: Árnason Faktor ehf.
Number: 5
Paid: 6.11.2023
Expires: 17.11.2024
Payer: Árnason Faktor ehf.
Number: 6
Paid: 15.10.2024
Expires: 17.11.2025
Payer: Árnason Faktor ehf.
Number: 7
Paid: 7.11.2025
Expires: 17.11.2026
Payer: Árnason Faktor ehf.